Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA1 | P00915 | 3/20 | 0.41 |
| ▸ | CA2 | P00918 | 3/20 | 0.41 |
| ▸ | CA12 | O43570 | 2/20 | 0.41 |
| ▸ | CA7 | P43166 | 2/20 | 0.41 |
| ▸ | CA9 | Q16790 | 2/20 | 0.41 |
| ▸ | CA14 | Q9ULX7 | 2/20 | 0.41 |
| ▸ | ACHE | P22303 | 1/20 | 0.41 |
| ▸ | IAPP | P10997 | 3/20 | 0.39 |
| ▸ | ELANE | P08246 | 1/20 | 0.39 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.39 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.39 |
| ▸ | ESR1 | P03372 | 2/20 | 0.39 |
| ▸ | HIF1A | Q16665 | 2/20 | 0.39 |
| ▸ | RECQL | P46063 | 1/20 | 0.39 |
| ▸ | SLC2A1 | P11166 | 1/20 | 0.38 |
| ▸ | SLC2A4 | P14672 | 1/20 | 0.38 |
| ▸ | NLRP3 | Q96P20 | 1/20 | 0.38 |
| ▸ | ACLY | P53396 | 1/20 | 0.36 |
| ▸ | CES2 | O00748 | 1/20 | 0.35 |
| ▸ | CES1 | P23141 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1992937 | 0.89 | KMT2A (0.45) | ACHEELANEKMT2ASMN1; SMN2ESR1 | |
| SCHEMBL289563 | 0.87 | CA1 (0.47) | CA1CA2CA12CA7CA9 | |
| SCHEMBL7849303 | 0.84 | IAPP (0.46) | IAPPKMT2ASMN1; SMN2RECQLMEN1 | |
| SCHEMBL8830200 | 0.81 | ACHE (0.40) | ACHEELANEKMT2ASMN1; SMN2ESR1 | |
| SCHEMBL7390728 | 0.81 | ACHE (0.43) | ACHEELANEKMT2ASMN1; SMN2ESR1 | |
| SCHEMBL7508588 | 0.81 | SMN1; SMN2 (0.43) | ACHEELANEKMT2ASMN1; SMN2ACLY | |
| SCHEMBL24436699 | 0.80 | KDM4E (0.45) | CA1CA2CA12CA7CA9 | |
| Hydrochloric Acid SCHEMBL28159059 | 0.80 | ACHE (0.42) | ACHEELANEKMT2ASMN1; SMN2ESR1 | |
| SCHEMBL2398457 | 0.80 | KMT2A (0.52) | CA1CA2CA12CA7CA9 | |
| SCHEMBL2671806 | 0.79 | ACHE (0.47) | CA1CA2CA12CA7CA9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7094926-B2 | Process for producing optically active carboxylic acid substituted in 2-position | KANEKA CORPORATION (JP) | 2006-08-22 | — | — | US | disclosed |
| US-20030144546-A1 | Process for producing optically active carboxylic acid subtituted in 2-position | KANEKA CORPORATION (JP) | 2003-07-31 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030144546-A1 | Process for producing optically active carboxylic acid subtituted in 2-position | HAO2, CA2, HACL2 | CA1 4/4885CA2 2/4885CA12 172/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.